Natural Food & Pharmaceuticals Corp announced that it expects to receive KRW 3 billion in funding from Susung Asset Management Co., Ltd., KB Securities Co., Ltd., Investment Arm, and another investor
March 28, 2017
Share
Natural Food & Pharmaceuticals Corp (XKON:A086220) announced a private placement of 18th series unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 3,000,000,000 on March 29, 2017. The bonds will be issued at par. The transaction will include participation from new investors Susung Asset Management Co., Ltd. for KRW 1,500,000,000, Hands Partners Corporation for KRW 1,200,000,000, and KB Securities Co., Ltd., Investment Arm for KRW 300,000,000. The bonds will mature on March 30, 2020. The bonds carry fixed coupon rate of 1% and yield to maturity of 4%. The bonds are 100% convertible into common shares at KRW 3,500 per share from March 30, 2018 to February 29, 2020. The transaction has been approved by the board of directors of the company. The transaction is expected to be completed by March 30, 2017.
Kwangdong Healthbio Co Ltd, formerly BL Healthcare Corp, is a Korea-based company mainly engaged in functional food manufacturing business. The Companyâs product portfolio consists of functional health food and cosmetic products. The functional food products mainly include coleus extract, seed oil and other fruit extract products used for various purposes such as blood sugar control, lowering cholesterol, lowering body fat, and supplementing trace elements. The cosmetic products mainly include bio-cell masks. The Company is also engaged in the pickled ginseng sale business.
Natural Food & Pharmaceuticals Corp announced that it expects to receive KRW 3 billion in funding from Susung Asset Management Co., Ltd., KB Securities Co., Ltd., Investment Arm, and another investor